Gestational age at RAL initiation (weeks, days) Reason for Raltegravir Use VL at RAL initiation (copies/mL) ARV drugs during pregnancy Gestational age at delivery (weeks, days) Exposure to RAL (days) VL at delivery (copies/mL) Decline of VL (log) from RAL initiation to delivery
38,4 Rapid viral suppression 5,613 FTC+TDF+ATV/r+RAL 39, 3 6 <20 2.45
38,4 Rapid viral suppression 96, 557 FTC+TDF+LPV/r+RAL 37, 3 6 30, 84 1.50
37,5 Rapid viral suppression 351,321 ZVD+3TC+LPV/r+RAL 38, 6 8 7, 74 1.70
21,1 Transaminitis from LPV/r 20,670 FTC+TDF+RAL 40, 1 133 - 3.01
31,1 Rapid viral suppression 61,496 ZVD+3TC+RAL 38, 1 49 911 1.83
39,6 Rapid viral suppression 71,660 FTC+TDF+ LPV/r+RAL 40, 2 2 13,717 0.72
33,3 Rapid viral suppression 201 FTC+TDF+ LPV/r+RAL 34, 1 5 66 0.48
35,0 Rapid viral suppression 321 FTC+TDF+LPV/r+RAL 36,2 9 26 1.09
Table 1: Viral load not reported at delivery- viral load <20 at 21 days prior and 49 days after delivery.